ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

iShares US Medical Devices ETF

Vanguard Dividend Appreciation ETF

Invesco OFI International Growth

Invesco Oppenheimer International Gr A

State St S&P 500® Indx SL Cl III

Blackrock Eq Idx Fund CF

Invesco S&P 500® Equal Weight ETF

Vanguard Health Care ETF

iShares Russell Mid-Cap ETF

Blackrock Russ 1000 Eq Idx Composite

Vanguard Mid Cap Index Institutional

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

iShares Core S&P 500 ETF

Vanguard Growth Index Investor

The Health Care Select Sector SPDR® ETF

Vanguard Mid-Cap Growth ETF

Vanguard Institutional Index I

Vanguard Group Inc

BlackRock Inc

Goldman Sachs Group Inc

UBS Asset Mgmt Americas Inc

Greenvale Capital LLP

Dimensional Fund Advisors, Inc.

JPMorgan Chase & Co

Congress Asset Management Company, LLP

Amundi

LGT Capital Partners Ltd.

Tandem Investment Advisors Inc

Coatue Management LLC

State Street Corp

Bank of New York Mellon Corp

Morgan Stanley - Brokerage Accounts

Geode Capital Management, LLC

Amvescap Plc.

Northern Trust Corp

Legal & General Group PLC

Charles Schwab Investment Management Inc

ResMed Inc

Mr. Michael J. Farrell BE, MBA, SM

CEO & Chairman

Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD

Founder, Chair Emeritus & Director

Mr. Brett A. Sandercock

Chief Financial Officer

Mr. Michael J. Rider

Chief Legal Officer & Secretary

Mr. Justin  Leong

Chief Product Officer

Mr. Kaushik  Ghoshal

Chief Commercial Officer - SaaS

Mr. Alastair  Robertson

Chief Information Officer

Mr. Jim  Ellis

Chief Compliance Officer

Ms. Yvonne-Katrin  Pucknat

Chief Marketing Officer

Ms. Vered  Keisar

Chief People Officer

RMD's next earnings is on January 22, 2025 (Before Market Open)

RMD's latest dividend is 0.53 USD on August 15, 2024

ResMed Inc (RMD) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

ResMed Inc (RMD) Earnings Report Date and History | NYSE

RMD's next earnings is on January 22, 2025 (Before Market Open)

When is the earnings report for RMD?

RMD Earnings History

RMD's latest dividend is 0.53 USD on August 15, 2024

RMD Stock Discussion Forum and Message Board

News for NYSE: RMD